美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

CLIMB BIO INC

7.34

+0.07501.03%

成交量：2.38万

成交额：17.41万

市值：3.50亿

市盈率：-8.17

高：7.43

开：7.29

低：7.19

收：7.26

52周最高：8.04

52周最低：1.05

股本：4,776.80万

流通股本：3,059.99万

量比：0.30

换手率：0.08%

股息：- -

股息率：- -

每股收益(TTM):-0.8974

每股收益(LYR):-0.8974

净资产收益率：-32.15%

总资产收益率：-22.04%

市净率：2.18

市盈率(LYR):-8.17

数据加载中...

总览公司新闻资讯公告

Climb Bio, Inc.盘中异动早盘股价大跌5.20%

CLIMB BIO INC：Budoprutug Prismn二期PMN试验完成首例患者给药，初步数据预计2026年下半年公布

Climb Bio, Inc.盘中异动早盘股价大跌5.07%

CLIMB BIO INC遭诉讼原告寻求法院确认Budoprutug候选药物不适用APA"产品"定义

CLIMB BIO INC：无需就布多普鲁替格研发向Alumis支付里程碑款项

Climb Bio公司就2024年1月11日资产购买协议纠纷提起诉讼

Climb Bio, Inc.盘中异动股价大涨5.61%

新闻稿：Climb Bio 根据纳斯达克上市规则 5635(c)(4) 报告激励股票奖励

CLIMB BIO INC 任命 Adam Villa 为技术运营高级副总裁，Ashley Jones 为人力资源与战略高级副总裁

Climb Bio任命Susan Altschuller博士为首席财务官

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/CLYM/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CLYM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLYM\",,,,,undefined,":{"symbol":"CLYM","market":"US","secType":"STK","nameCN":"CLIMB BIO INC","latestPrice":7.335,"timestamp":1773411845382,"preClose":7.26,"halted":0,"volume":23847,"delay":0,"changeRate":0.010330578512396719,"floatShares":30599941,"shares":47768000,"eps":-0.897422,"marketStatus":"交易中","change":0.075,"latestTime":"03-13 10:24:25 EDT","open":7.29,"high":7.4275,"low":7.19,"amount":174136.3670439,"amplitude":0.032713,"askPrice":7.4,"askSize":100,"bidPrice":7.27,"bidSize":134,"shortable":3,"etf":0,"ttmEps":-0.897422,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1773432000000},"marketStatusCode":2,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":7.26,"preHourTrading":{"tag":"盘前","latestPrice":7.11,"preClose":7.26,"latestTime":"08:45 EDT","volume":80,"amount":572.99,"timestamp":1773405935211,"change":-0.15,"changeRate":-0.020661,"amplitude":0.026171},"postHourTrading":{"tag":"盘后","latestPrice":7.26,"preClose":7.26,"latestTime":"17:30 EDT","volume":11431,"amount":82992.51,"timestamp":1773351049394,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.302734,"impliedVol":2.625,"impliedVolPercentile":0.3611},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLYM\",,,,,undefined,":{"symbol":"CLYM","floatShares":30599941,"roa":"-22.04%","roe":"-32.15%","lyrEps":-0.897422,"volumeRatio":0.302734,"shares":47768000,"dividePrice":0,"high":7.4275,"amplitude":0.032713,"preClose":7.26,"low":7.19,"week52Low":1.05,"pbRate":"2.18","week52High":8.04,"institutionHeld":0,"latestPrice":7.335,"committee":0.145299,"eps":-0.897422,"divideRate":0,"volume":23847,"delay":0,"ttmEps":-0.897422,"open":7.29,"prevYearClose":4,"prevWeekClose":7.18,"prevMonthClose":7.15,"prevQuarterClose":4,"fiveDayClose":7.18,"twentyDayClose":5.27,"sixtyDayClose":3.81},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CLYM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-05","symbol":"CLYM","fiscalQuarterEnding":"2025/12","expectedEps":-0.2,"name":null,"time":"盘前","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2025-11-06","symbol":"CLYM","fiscalQuarterEnding":"2025/09","expectedEps":-0.16,"name":null,"time":"盘前","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.19},{"market":"US","date":"2025-08-12","symbol":"CLYM","fiscalQuarterEnding":"2025/06","expectedEps":-0.19,"name":null,"time":"盘前","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2021-09-13","symbol":"CLYM","fiscalQuarterEnding":"2021/06","expectedEps":-2.3,"name":null,"time":"","type":"earning","dateTimestamp":1631505600000,"reportTimeType":"","actualEps":-3.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CLYM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CLYM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.7,"buy":0.3,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.7,"analysts":10,"updateTime":1773201600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CLYM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CLYM","date":"2026-03-12","current":-8.08984,"percent":0.033613,"low":-6.942798,"twenty":-3.982297,"median":-2.502537,"eighty":-1.150507,"high":-0.85032,"avg":-2.675071,"sd":1.557663,"marketCap":350139293},"quantilePoints":[{"date":"2024-10-04","current":-5.327624,"twenty":-5.327624,"median":-5.327624,"eighty":-5.327624,"marketCap":342006831},{"date":"2024-10-11","current":-5.369409,"twenty":-5.463426,"median":-5.390302,"eighty":-5.369409,"marketCap":344689237},{"date":"2024-10-18","current":-5.076912,"twenty":-5.494765,"median":-5.390302,"eighty":-5.327624,"marketCap":325912392},{"date":"2024-10-25","current":-4.85754,"twenty":-5.463426,"median":-5.327624,"eighty":-5.014234,"marketCap":311829757},{"date":"2024-10-31","current":-4.094958,"twenty":-5.404927,"median":-5.238831,"eighty":-4.776059,"marketCap":262875838},{"date":"2024-11-08","current":-3.677105,"twenty":-5.390302,"median":-5.014234,"eighty":-4.074065,"marketCap":236051773},{"date":"2024-11-15","current":-3.107258,"twenty":-5.373588,"median":-4.888879,"eighty":-3.806639,"marketCap":214779913},{"date":"2024-11-22","current":-2.917613,"twenty":-5.335981,"median":-4.293438,"eighty":-3.619939,"marketCap":201671280},{"date":"2024-11-29","current":-3.141297,"twenty":-5.327624,"median":-4.220314,"eighty":-3.127681,"marketCap":217132744},{"date":"2024-12-06","current":-2.830085,"twenty":-5.277482,"median":-3.974826,"eighty":-3.040153,"marketCap":195621141},{"date":"2024-12-13","current":-2.742557,"twenty":-5.237786,"median":-3.781569,"eighty":-2.995417,"marketCap":189571003},{"date":"2024-12-20","current":-1.896449,"twenty":-5.13959,"median":-3.671882,"eighty":-2.96235,"marketCap":131086332},{"date":"2024-12-27","current":-2.207661,"twenty":-5.051841,"median":-3.301766,"eighty":-2.921503,"marketCap":152597935},{"date":"2025-01-03","current":-2.013153,"twenty":-5.003788,"median":-3.151022,"eighty":-2.57139,"marketCap":139153183},{"date":"2025-01-10","current":-1.818646,"twenty":-4.962003,"median":-3.124277,"eighty":-2.236837,"marketCap":125708431},{"date":"2025-01-17","current":-1.954801,"twenty":-4.920218,"median":-3.063494,"eighty":-2.032604,"marketCap":135119757},{"date":"2025-01-24","current":-1.770019,"twenty":-4.870076,"median":-3.005142,"eighty":-1.952856,"marketCap":122347243},{"date":"2025-01-31","current":-1.876998,"twenty":-4.531614,"median":-2.995417,"eighty":-1.91979,"marketCap":129741856},{"date":"2025-02-07","current":-1.701941,"twenty":-4.324777,"median":-2.96624,"eighty":-1.892559,"marketCap":117641580},{"date":"2025-02-14","current":-1.546335,"twenty":-4.251653,"median":-2.932201,"eighty":-1.865328,"marketCap":106885778},{"date":"2025-02-21","current":-1.400454,"twenty":-4.228671,"median":-2.873849,"eighty":-1.840042,"marketCap":96802214},{"date":"2025-02-28","current":-1.351828,"twenty":-4.1451,"median":-2.528598,"eighty":-1.818646,"marketCap":93441026},{"date":"2025-03-07","current":-1.429631,"twenty":-4.03228,"median":-2.256288,"eighty":-1.756403,"marketCap":98818927},{"date":"2025-03-14","current":-1.293475,"twenty":-3.971692,"median":-2.18821,"eighty":-1.542445,"marketCap":89407600},{"date":"2025-03-21","current":-1.244848,"twenty":-3.871407,"median":-2.022879,"eighty":-1.474368,"marketCap":86046412},{"date":"2025-03-28","current":-1.159638,"twenty":-3.794104,"median":-1.954801,"eighty":-1.429631,"marketCap":85693751},{"date":"2025-04-04","current":-1.050066,"twenty":-3.724618,"median":-1.940213,"eighty":-1.381004,"marketCap":77596704},{"date":"2025-04-11","current":-1.059197,"twenty":-3.680923,"median":-1.925625,"eighty":-1.357663,"marketCap":78271458},{"date":"2025-04-17","current":-1.150507,"twenty":-3.672927,"median":-1.896449,"eighty":-1.324596,"marketCap":85018997},{"date":"2025-04-25","current":-1.187031,"twenty":-3.573219,"median":-1.876998,"eighty":-1.28764,"marketCap":87718013},{"date":"2025-05-02","current":-1.150507,"twenty":-3.328025,"median":-1.867273,"eighty":-1.252628,"marketCap":85018997},{"date":"2025-05-09","current":-1.088206,"twenty":-3.166583,"median":-1.847822,"eighty":-1.218825,"marketCap":80415162},{"date":"2025-05-16","current":-0.872124,"twenty":-3.152968,"median":-1.818646,"eighty":-1.187031,"marketCap":81090920},{"date":"2025-05-23","current":-0.872124,"twenty":-3.141297,"median":-1.818646,"eighty":-1.164325,"marketCap":81090920},{"date":"2025-05-30","current":-0.886659,"twenty":-3.134489,"median":-1.784607,"eighty":-1.159638,"marketCap":82442435},{"date":"2025-06-06","current":-0.901194,"twenty":-3.10434,"median":-1.750568,"eighty":-1.150507,"marketCap":83793951},{"date":"2025-06-13","current":-0.930265,"twenty":-3.086835,"median":-1.590099,"eighty":-1.125277,"marketCap":86496981},{"date":"2025-06-20","current":-0.893927,"twenty":-3.063494,"median":-1.522022,"eighty":-1.106495,"marketCap":83118193},{"date":"2025-06-27","current":-0.91573,"twenty":-3.014867,"median":-1.478258,"eighty":-1.095721,"marketCap":85145466},{"date":"2025-07-03","current":-0.930265,"twenty":-3.007087,"median":-1.439356,"eighty":-1.066502,"marketCap":86496981},{"date":"2025-07-11","current":-0.981139,"twenty":-2.997362,"median":-1.429631,"eighty":-1.007303,"marketCap":91227285},{"date":"2025-07-18","current":-1.061084,"twenty":-2.995417,"median":-1.400454,"eighty":-0.995674,"marketCap":98660619},{"date":"2025-07-25","current":-1.075619,"twenty":-2.995417,"median":-1.376141,"eighty":-1.007303,"marketCap":100012135},{"date":"2025-08-01","current":-1.017477,"twenty":-2.979856,"median":-1.361553,"eighty":-1.016024,"marketCap":94606073},{"date":"2025-08-08","current":-1.220973,"twenty":-2.968185,"median":-1.346965,"eighty":-1.017477,"marketCap":113527288},{"date":"2025-08-15","current":-2.492713,"twenty":-2.95846,"median":-1.351828,"eighty":-1.023291,"marketCap":116554252},{"date":"2025-08-22","current":-3.173861,"twenty":-2.979856,"median":-1.366416,"eighty":-1.024745,"marketCap":148403379},{"date":"2025-08-29","current":-3.333278,"twenty":-3.007087,"median":-1.381004,"eighty":-1.030392,"marketCap":155857430},{"date":"2025-09-05","current":-3.376756,"twenty":-3.075164,"median":-1.400454,"eighty":-1.031929,"marketCap":157890353},{"date":"2025-09-12","current":-3.478204,"twenty":-3.149077,"median":-1.429631,"eighty":-1.042845,"marketCap":162633840},{"date":"2025-09-19","current":-3.246323,"twenty":-3.164638,"median":-1.439356,"eighty":-1.052316,"marketCap":151791584},{"date":"2025-09-26","current":-3.043428,"twenty":-3.197049,"median":-1.483121,"eighty":-1.053816,"marketCap":142304610},{"date":"2025-10-03","current":-2.956473,"twenty":-3.173861,"median":-1.53661,"eighty":-1.057045,"marketCap":138238764},{"date":"2025-10-10","current":-2.739085,"twenty":-3.171828,"median":-1.667902,"eighty":-1.060329,"marketCap":128074149},{"date":"2025-10-17","current":-2.82604,"twenty":-3.164638,"median":-1.760293,"eighty":-1.06543,"marketCap":132139995},{"date":"2025-10-24","current":-2.88401,"twenty":-3.171828,"median":-1.808921,"eighty":-1.072703,"marketCap":134850559},{"date":"2025-10-31","current":-2.88401,"twenty":-3.164638,"median":-1.818646,"eighty":-1.075619,"marketCap":134850559},{"date":"2025-11-07","current":-2.603692,"twenty":-3.149077,"median":-1.838097,"eighty":-1.083171,"marketCap":132139995},{"date":"2025-11-14","current":-2.512362,"twenty":-3.141297,"median":-1.857547,"eighty":-1.088206,"marketCap":127504893},{"date":"2025-11-21","current":-2.324271,"twenty":-3.120874,"median":-1.876998,"eighty":-1.092715,"marketCap":117959072},{"date":"2025-11-28","current":-2.539232,"twenty":-3.101423,"median":-1.886723,"eighty":-1.096373,"marketCap":128868582},{"date":"2025-12-05","current":-2.324271,"twenty":-3.090364,"median":-1.896449,"eighty":-1.097379,"marketCap":117959072},{"date":"2025-12-12","current":-3.090071,"twenty":-3.088805,"median":-1.930487,"eighty":-1.097422,"marketCap":156824200},{"date":"2025-12-19","current":-5.88457,"twenty":-3.141297,"median":-1.945076,"eighty":-1.098568,"marketCap":298647825},{"date":"2025-12-26","current":-4.562679,"twenty":-3.173183,"median":-1.969389,"eighty":-1.101167,"marketCap":231560509},{"date":"2026-01-02","current":-3.763034,"twenty":-3.231831,"median":-2.032604,"eighty":-1.10469,"marketCap":190977740},{"date":"2026-01-09","current":-4.308674,"twenty":-3.260816,"median":-2.195782,"eighty":-1.104852,"marketCap":218669512},{"date":"2026-01-16","current":-3.54666,"twenty":-3.333278,"median":-2.236837,"eighty":-1.106495,"marketCap":179996519},{"date":"2026-01-23","current":-4.619124,"twenty":-3.365162,"median":-2.283966,"eighty":-1.112485,"marketCap":234425175},{"date":"2026-01-30","current":-4.496826,"twenty":-3.449218,"median":-2.324271,"eighty":-1.121288,"marketCap":228218399},{"date":"2026-02-06","current":-4.374527,"twenty":-3.488132,"median":-2.337706,"eighty":-1.123114,"marketCap":222011622},{"date":"2026-02-13","current":-4.957797,"twenty":-3.580579,"median":-2.363428,"eighty":-1.131766,"marketCap":251613172},{"date":"2026-02-20","current":-5.305878,"twenty":-3.670837,"median":-2.397337,"eighty":-1.138397,"marketCap":269278613},{"date":"2026-02-27","current":-6.942798,"twenty":-3.770448,"median":-2.418317,"eighty":-1.146855,"marketCap":352353930},{"date":"2026-03-06","current":-5.895163,"twenty":-3.911674,"median":-2.457761,"eighty":-1.150507,"marketCap":352831374},{"date":"2026-03-12","current":-5.850183,"twenty":-3.982297,"median":-2.502537,"eighty":-1.150507,"marketCap":350139293}],"updateTime":1773405613384},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CLYM\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610931045","title":"Climb Bio, Inc.盘中异动 早盘股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610931045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610931045?lang=zh_cn&edition=fundamental","pubTime":"2026-02-10 22:49","pubTimestamp":1770734993,"startTime":"0","endTime":"0","summary":"北京时间2026年02月10日22时49分，Climb Bio, Inc.股票出现异动，股价快速下挫5.20%。截至发稿，该股报5.47美元/股，成交量4.4672万股，换手率0.07%，振幅5.55%。Climb Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Climb Bio, Inc.公司简介：Climb Bio Inc是一家临床阶段的生物技术公司，为免疫介导性疾病患者开发治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021022495495409ea2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021022495495409ea2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CLYM"],"gpt_icon":0},{"id":"1117014745","title":"CLIMB BIO INC：Budoprutug Prismn二期PMN试验完成首例患者给药，初步数据预计2026年下半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1117014745","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117014745?lang=zh_cn&edition=fundamental","pubTime":"2026-01-08 20:04","pubTimestamp":1767873896,"startTime":"0","endTime":"0","summary":"CLIMB BIO INC宣布，其针对PMN（进行性多发性神经病）的Budoprutug Prismn二期临床试验已完成首例患者给药。该试验旨在评估候选药物的安全性与有效性，预计将于2026年下半年获得初步研究数据。这一里程碑标志着公司在神经疾病治疗领域的研发推进取得重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","CLYM"],"gpt_icon":0},{"id":"2601186879","title":"Climb Bio, Inc.盘中异动 早盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601186879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601186879?lang=zh_cn&edition=fundamental","pubTime":"2026-01-05 23:04","pubTimestamp":1767625482,"startTime":"0","endTime":"0","summary":"北京时间2026年01月05日23时04分，Climb Bio, Inc.股票出现异动，股价大幅跳水5.07%。截至发稿，该股报3.56美元/股，成交量16.0404万股，换手率0.24%，振幅7.15%。Climb Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.48%。Climb Bio, Inc.公司简介：Climb Bio Inc是一家临床阶段的生物技术公司，为免疫介导性疾病患者开发治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105230442953c04f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105230442953c04f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLYM","BK4539"],"gpt_icon":0},{"id":"1179806903","title":"CLIMB BIO INC遭诉讼 原告寻求法院确认Budoprutug候选药物不适用APA\"产品\"定义","url":"https://stock-news.laohu8.com/highlight/detail?id=1179806903","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179806903?lang=zh_cn&edition=fundamental","pubTime":"2026-01-01 05:16","pubTimestamp":1767215795,"startTime":"0","endTime":"0","summary":"一家生物制药企业陷入法律争议漩涡。最新提交的司法文件显示，有原告方针对CLIMB BIO INC提起诉讼，要求法院作出宣告式判决，确认该公司旗下实验性药物Budoprutug不符合《美国药品价格竞争与专利期补偿法案》（APA）中关于\"产品\"的法定定义。\n这场法律博弈的核心在于对APA条款的司法解释。原告方主张，Budoprutug作为尚处于研发阶段的候选药物，其法律属性不应被归类为APA监管框架下的\"产品\"。若法院支持这一主张，或将影响该药物未来面临专利链接制度约束的时点。\n目前案件仍在司法程序中，最终裁决结果可能为生物技术行业带来新的判例参考。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLYM","BK4539","BK4139"],"gpt_icon":0},{"id":"1182063019","title":"CLIMB BIO INC：无需就布多普鲁替格研发向Alumis支付里程碑款项","url":"https://stock-news.laohu8.com/highlight/detail?id=1182063019","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182063019?lang=zh_cn&edition=fundamental","pubTime":"2026-01-01 05:16","pubTimestamp":1767215781,"startTime":"0","endTime":"0","summary":"CLIMB BIO INC（简称：CLYM）正式声明，公司不应承担Alumis就其研发药物布多普鲁替格（Budoprutug）所追索的里程碑付款义务。这一立场凸显了双方在合作协议条款理解上的根本分歧。\n目前，CLIMB BIO INC正全力推进布多普鲁替格的临床开发进程。公司强调，其所有财务义务均严格遵循既有合同约定，不存在Alumis所主张的付款责任。此次争议的解决将直接影响后续研发资源的配置与合作伙伴关系的走向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CLYM"],"gpt_icon":0},{"id":"1197140729","title":"Climb Bio公司就2024年1月11日资产购买协议纠纷提起诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=1197140729","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197140729?lang=zh_cn&edition=fundamental","pubTime":"2026-01-01 05:15","pubTimestamp":1767215711,"startTime":"0","endTime":"0","summary":"生物技术企业Climb Bio Inc（股票代码：CLYM）近日因资产收购协议争议正式向法院提交诉状。该协议签署于2024年1月11日，涉及核心资产交易条款的履行分歧。诉讼文件显示，双方对协议中约定的权利义务存在实质性认知差异，可能影响公司后续业务整合进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","CLYM"],"gpt_icon":0},{"id":"2593435400","title":"Climb Bio, Inc.盘中异动 股价大涨5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593435400","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593435400?lang=zh_cn&edition=fundamental","pubTime":"2025-12-22 22:31","pubTimestamp":1766413863,"startTime":"0","endTime":"0","summary":"北京时间2025年12月22日22时31分，Climb Bio, Inc.股票出现波动，股价快速拉升5.61%。Climb Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Equillium, Inc.、Quantum Biopharma Ltd.涨幅较大，Pmgc Holdings Inc.、Psyence Biomedical Ltd.、Gt Biopharma, Inc.较为活跃，换手率分别为112.17%、15.05%、7.48%，振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Quantum Biopharma Ltd.、Gain Therapeutics, Inc.，振幅分别为9.31%、6.97%、6.53%。Climb Bio, Inc.公司简介：Climb Bio Inc是一家临床阶段的生物技术公司，为免疫介导性疾病患者开发治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222223103a46ae0ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222223103a46ae0ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CLYM"],"gpt_icon":0},{"id":"1191476710","title":"新闻稿：Climb Bio 根据纳斯达克上市规则 5635(c)(4) 报告激励股票奖励","url":"https://stock-news.laohu8.com/highlight/detail?id=1191476710","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191476710?lang=zh_cn&edition=fundamental","pubTime":"2025-11-25 20:07","pubTimestamp":1764072421,"startTime":"0","endTime":"0","summary":"美国马萨诸塞州韦尔斯利山，2025年11月25日-- Climb Bio, Inc.，一家开发针对免疫介导疾病的治疗药物的临床阶段生物技术公司，今天宣布，Climb Bio 根据其2025年修订的激励计划，向一名新员工授予了激励股票奖励，以激励该名员工与 Climb Bio 签署雇佣合同，符合纳斯达克上市规则 5635。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TQQQ",".IXIC","NVIW.SI","USAW.SI","USJW.SI","BK4539","QQQ","CLYM","PSQ","TSYW.SI","NQmain","QID","SQQQ","MNQmain","BK4139","QLD"],"gpt_icon":1},{"id":"1185490852","title":"CLIMB BIO INC 任命 Adam Villa 为技术运营高级副总裁，Ashley Jones 为人力资源与战略高级副总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=1185490852","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185490852?lang=zh_cn&edition=fundamental","pubTime":"2025-10-21 19:02","pubTimestamp":1761044546,"startTime":"0","endTime":"0","summary":"CLIMB BIO INC 任命 Adam Villa 为技术运营高级副总裁，Ashley Jones 为人力资源与战略高级副总裁。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","CLYM"],"gpt_icon":0},{"id":"1132044705","title":"Climb Bio任命Susan Altschuller博士为首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1132044705","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132044705?lang=zh_cn&edition=fundamental","pubTime":"2025-10-01 19:05","pubTimestamp":1759316756,"startTime":"0","endTime":"0","summary":"马萨诸塞州韦尔斯利山，2025年10月1日——临床阶段生物技术公司Climb Bio Inc.今日宣布，公司通过任命Susan Altschuller博士为首席财务官来加强领导团队。Susan拥有超过二十年的战略和财务领导经验。\"我被Climb Bio的愿景以及其研发管线解决严重免疫介导疾病的潜力所鼓舞，\"Climb Bio即将上任的首席财务官Susan Altschuller表示。激励性授予须遵守奖励协议条款和Climb Bio 2025年激励计划的条件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CLYM","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}